Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Ovarian function suppression appears comparable to chemotherapy in young women
February 2nd, 2006
Ovarian function suppression appears to be comparable to chemotherapy in very young women with breast cancer. According to a researcher in Switzerland, "A small minority of breast cancer patients consists of young women (<40 years: <6%). Thus, they may not be properly represented in clinical trials. They present with unfavorable tumor characteristics, but young age is an independent negative prognosticator: age is a surrogate for biological mechanisms determining an aggressive cancer phenotype." S. Aebi cited, "In premenopausal patients with estrogen receptor-positive (ER+) tumors, adjuvant ovarian function suppression (OSF) was as effective as...
Source: Women's Health Weekly (2006-02-02)
|
